Once-troubled Verastem wins FDA nod for AbbVie-abandoned lymphoma drug Copiktra
admin 25th September 2018 Uncategorised 0Verastem Oncology has come a long way from the major failure of its lead candidate defactinib to its first FDA approval. And it’s done it with a drug that itself had a troubled past.
More: Once-troubled Verastem wins FDA nod for AbbVie-abandoned lymphoma drug Copiktra
Source: fierce